Phosphatidylserine/Prothrombin (PS/PT) Antibody (IgM)

The Phosphatidylserine/Prothrombin (PS/PT) Antibody (IgM) test contains 1 test with 1 biomarker.

Phosphatidylserine/Prothrombin (PS/PT) Antibody (IgM)

Clinical Significance
Phosphatidylserine/Prothrombin (PS/PT) Antibody (IgM) - Antiphospholipid Syndrome (APS) is an acquired autoimmune thrombophilia characterized by thrombosis (venous and/or arterial or microvascular) and/or pregnancy loss or morbidity in association with persistent positivity of a heterogenous group of autoantibodies known as anti- phospholipid antibodies (APL).
The international laboratory consensus criteria for the diagnosis of APS includes a positive lupus anticoagulant and/or moderate to high positivity for IgG/IgM Cardiolipin and Beta-2-Glycoprotein I antibodies. Although not included in the criteria classification for APS diagnosis, antibodies directed against a phosphatidylserine/prothrombin complex (PS/PT) have been reported to have a high association with venous thrombosis and obstetric abnormalities, but not with arterial thrombosis. In addition, a very high degree of concordance between the concentration of aPS/PT and lupus anticoagulant activity has been demonstrated.

Reference Range(s)
≤30 U

Alternative Name(s)
PSPT IgM Antibodies,aPS/PT IgM